Delvin commenced its generic formulation business in 2009 and is today spread across its presence from API to formulation, Medical devices, Formulation exports and Wellness products.
Delvin created a unique identity among customers by bringing novel formulations which helps to alleviate the sufferings of millions.
In last 9 years we carved a niche name among doctors and patients by offering innovative formulations in Specialties such as Gastroenterology, Neurology, Psychiatry, Orthopedics and in Infertility. Our products are well appreciated in terms of innovation and the benefit it offers to patients.
We are committed to widening access to our products by acquiring Sai Mirra Innopharm a PIC/s accredited facility, so people across the globe can access our innovative and world-class healthcare products.
To augment our passion to offer innovative products we started NuRay Chemicals a US FDA approved API facility. NuRay Chemicals offers very unique product portfolio and having good customer franchise from US and Europe.
In order to expand our presence in other Pharma verticals we have started Delvin Surgicals, where we are marketing unique products in critical care.
